The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Loose Christopher R. since 2020.
This trader's CIK number is 1785299.
At the time of last reporting, Loose Christopher R. was the Chief Scientific Officer of Frequency Therapeutics, Inc.. (stock ticker symbol FREQ).
Also see all insider trading activities at Frequency Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | FREQ | 0 | $0 | 22,729 | $11,321 | 18,184 | $0 |
| 2022 | FREQ | 0 | $0 | 9,072 | $25,578 | 30,000 | $0 |
| 2021 | FREQ | 0 | $0 | 18,000 | $794,580 | 0 | $0 |
| 2020 | FREQ | 0 | $0 | 158,000 | $3,773,166 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-27 | FREQ | Sale | 1,373 | .53 | 727 |
| 2023-07-28 | FREQ | Sale | 1,344 | .46 | 618 |
| 2023-07-25 | FREQ | Sale | 1,390 | .50 | 695 |
| 2023-07-26 | FREQ | Sale | 1,329 | .51 | 677 |
| 2023-07-21 | FREQ | Sale | 1,333 | .61 | 813 |
| 2023-07-24 | FREQ | Sale | 1,438 | .54 | 776 |
| 2023-07-19 | FREQ | Sale | 1,335 | .65 | 867 |
| 2023-07-20 | FREQ | Sale | 1,361 | .64 | 871 |
| 2023-07-18 | FREQ | Sale | 1,484 | .56 | 831 |
| 2023-07-17 | FREQ | Sale | 1,415 | .67 | 948 |
| 2023-07-13 | FREQ | Sale | 1,329 | .39 | 518 |
| 2023-07-14 | FREQ | Sale | 906 | .59 | 534 |
| 2023-07-11 | FREQ | Sale | 1,363 | .37 | 504 |
| 2023-07-12 | FREQ | Sale | 1,335 | .39 | 520 |
| 2023-07-10 | FREQ | Sale | 1,304 | .37 | 482 |
| 2023-07-10 | FREQ | Option Ex | 4,546 | .00 | 0 |
| 2023-07-07 | FREQ | Sale | 1,306 | .36 | 470 |
| 2023-07-07 | FREQ | Option Ex | 4,546 | .00 | 0 |
| 2023-07-05 | FREQ | Option Ex | 4,546 | .00 | 0 |
| 2023-07-06 | FREQ | Option Ex | 4,546 | .00 | 0 |
| 2023-07-06 | FREQ | Sale | 1,384 | .34 | 470 |
| 2022-07-06 | FREQ | Sale | 4,415 | 1.53 | 6,754 |
| 2022-07-05 | FREQ | Option Ex | 15,000 | .00 | 0 |
| 2022-02-18 | FREQ | Sale | 974 | 3.87 | 3,772 |
| 2022-02-22 | FREQ | Sale | 1,069 | 3.53 | 3,773 |
| 2022-02-17 | FREQ | Sale | 900 | 4.19 | 3,773 |
| 2022-02-16 | FREQ | Sale | 851 | 4.43 | 3,769 |
| 2022-02-14 | FREQ | Option Ex | 15,000 | .00 | 0 |
| 2022-02-15 | FREQ | Sale | 863 | 4.33 | 3,737 |
| 2021-02-03 | FREQ | Sale | 2,000 | 47.19 | 94,380 |
| 2021-02-02 | FREQ | Sale | 8,000 | 45.02 | 360,200 |
| 2021-01-27 | FREQ | Sale | 8,000 | 42.50 | 340,000 |
| 2020-12-17 | FREQ | Sale | 8,000 | 41.25 | 330,000 |
| 2020-12-14 | FREQ | Sale | 8,000 | 35.00 | 280,000 |
| 2020-12-15 | FREQ | Sale | 8,000 | 37.28 | 298,240 |
| 2020-12-16 | FREQ | Sale | 8,000 | 38.94 | 311,480 |
| 2020-11-05 | FREQ | Sale | 8,000 | 23.00 | 184,000 |
| 2020-11-09 | FREQ | Sale | 8,000 | 24.00 | 192,000 |
| 2020-10-13 | FREQ | Sale | 8,000 | 22.00 | 176,000 |
| 2020-10-06 | FREQ | Sale | 8,000 | 19.46 | 155,680 |
| 2020-10-07 | FREQ | Sale | 8,000 | 20.00 | 160,008 |
| 2020-10-08 | FREQ | Sale | 8,000 | 21.12 | 168,960 |
| 2020-10-05 | FREQ | Sale | 8,000 | 18.35 | 146,800 |
| 2020-10-02 | FREQ | Sale | 8,000 | 18.92 | 151,360 |
| 2020-10-01 | FREQ | Sale | 8,000 | 18.84 | 150,720 |
| 2020-09-23 | FREQ | Sale | 4,500 | 21.50 | 96,763 |
| 2020-09-09 | FREQ | Sale | 4,500 | 19.08 | 85,878 |
| 2020-08-19 | FREQ | Sale | 4,500 | 22.97 | 103,351 |
| 2020-08-05 | FREQ | Sale | 4,500 | 21.56 | 97,006 |
| 2020-07-22 | FREQ | Sale | 4,500 | 21.51 | 96,790 |
| 2020-07-08 | FREQ | Sale | 4,500 | 22.58 | 101,592 |
| 2020-06-24 | FREQ | Sale | 4,500 | 22.80 | 102,586 |
| 2020-06-10 | FREQ | Sale | 4,500 | 19.96 | 89,829 |
| 2020-05-20 | FREQ | Sale | 4,500 | 19.07 | 85,824 |
| 2020-05-06 | FREQ | Sale | 4,500 | 16.45 | 74,038 |
| 2020-04-22 | FREQ | Sale | 4,500 | 14.84 | 66,793 |
| 2020-04-08 | FREQ | Sale | 4,500 | 14.99 | 67,468 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Loose Christopher R. (Chief Scientific Officer of Frequency Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.